Literature DB >> 19287982

Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma.

Takahiro Toyokawa1, Masakazu Yashiro, Kosei Hirakawa.   

Abstract

Keratinocyte growth factor (KGF) from gastric fibroblasts have been reported to stimulate proliferation of scirrhous gastric cancer cells with K-samII amplification in a paracrine manner. The aim of this study was to evaluate the clinical significance of the co-expression of K-sam and KGF in gastric carcinomas. A total of 136 primary gastric tumors were investigated by staining with antibodies against K-sam and KGF. K-sam expression on cancer cells and KGF expression on fibroblasts was estimated. The relationship between the K-sam and/or KGF expression and the clinicopathological characteristics were analyzed. K-sam expression was positive in 42 (31%) of 136 gastric carcinomas. K-sam expression was positively correlated with scirrhous cancer (p<0.001), diffuse type (p=0.031), invasion depth (p=0.018) and infiltration type (p<0.001). Prognosis of K-sam positive patients was significantly poorer than that of K-sam negative patients (p<0.001). The prognosis of patients with both K-sam and KGF positive tumors was significantly worse in comparison to either negative tumors (p<0.001). In 94 patients with a curative resection, a multivariate analysis revealed the co-expression of K-sam and KGF to be an independent prognostic factor (p=0.029). In conclusion, the co-expression of K-sam and KGF in gastric cancer might be a useful prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287982     DOI: 10.3892/or_00000297

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

1.  Cancer-stromal interactions in scirrhous gastric carcinoma.

Authors:  Masakazu Yashiro; Kosei Hirakawa
Journal:  Cancer Microenviron       Date:  2010-01-26

2.  FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.

Authors:  Soomin Ahn; Jeeyun Lee; Mineui Hong; Seung Tae Kim; Se Hoon Park; Min Gew Choi; Jun-Ho Lee; Tae Sung Sohn; Jae Moon Bae; Sung Kim; Sin-Ho Jung; Won Ki Kang; Kyoung-Mee Kim
Journal:  Mod Pathol       Date:  2016-05-27       Impact factor: 7.842

Review 3.  Genomic and genetic alterations influence the progression of gastric cancer.

Authors:  Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 4.  Pathogenetic mechanisms in gastric cancer.

Authors:  Jing Shi; Yi-Ping Qu; Peng Hou
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.

Authors:  Tarrik M Zaid; Tsz-Lun Yeung; Melissa S Thompson; Cecilia S Leung; Tom Harding; Ngai-Na Co; Rosie S Schmandt; Suet-Ying Kwan; Cristian Rodriguez-Aguay; Gabriel Lopez-Berestein; Anil K Sood; Kwong-Kwok Wong; Michael J Birrer; Samuel C Mok
Journal:  Clin Cancer Res       Date:  2013-01-23       Impact factor: 12.531

Review 6.  Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.

Authors:  Masakazu Yashiro; Tasuku Matsuoka
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

7.  Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.

Authors:  Hideaki Murase; Mikito Inokuchi; Yoko Takagi; Keiji Kato; Kazuyuki Kojima; Kenichi Sugihara
Journal:  Mol Clin Oncol       Date:  2014-05-15

8.  Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.

Authors:  Akiko Kawano Nagatsuma; Masaki Aizawa; Takeshi Kuwata; Toshihiko Doi; Atsushi Ohtsu; Hirofumi Fujii; Atsushi Ochiai
Journal:  Gastric Cancer       Date:  2014-03-14       Impact factor: 7.370

9.  Clinical significance of keratinocyte growth factor and K-sam gene expression in gastric cancer.

Authors:  Hideki Tani; Noboru Saito; Makio Kobayashi; Shingo Kameoka
Journal:  Mol Med Rep       Date:  2013-03-27       Impact factor: 2.952

10.  FGFR2 gene amplification and clinicopathological features in gastric cancer.

Authors:  K Matsumoto; T Arao; T Hamaguchi; Y Shimada; K Kato; I Oda; H Taniguchi; F Koizumi; K Yanagihara; H Sasaki; K Nishio; Y Yamada
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.